Comparison the Effect of Niacin Treatment with and without Atorvastatin on Lipid Profile in Type 2 Diabetic Patients
نویسندگان
1 Professor of Endocrinology & Metabolism, Department of Internal Medicine, School of Medicine, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Assistant Professor of Cardiology, Department of Cardiology, School of Medicine, Afshar Heart Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3 Obstetrics and Gynecology, Department of Obstetrics and Gynecology, School of Medicine, Shahid Sadoughi General Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 General Physician, Shahid Sadoughi University of Medical Science, Yazd, Iran.
5 Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran
doi
10.18502/ijdo.v12i3.4446چکیده
Objective: The risk of cardiovascular disease increased in diabetic patients due to lipoprotein metabolism disorder and insulin resistance. There is different type of dyslipidemia in diabetic patient. The nicotinic acid (niacin) is categorized as vitamin B family and decreases low-density lipoproteins (LDL) and triglyceride (TG) level and increases high-density lipoproteins (HDL). ...
